Question 1

What is Edward Margolin?

Accepted Answer

Edward Margolin is a Person.

Question 2

How often does Edward Margolin appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 13 articles.

Question 3

When was Edward Margolin first tracked by Ergen?

Accepted Answer

First tracked on Mar 10, 2026.

Question 4

When was Edward Margolin last mentioned in news?

Accepted Answer

Last active on Mar 11, 2026.

Question 5

What is Edward Margolin's current news sentiment?

Accepted Answer

Aggregate sentiment score: 0 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Edward Margolin in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Edward Margolin?

Accepted Answer

Wegovy Linked to Sight Loss Risk (Mar 10, 2026, 13 articles).

Question 8

How did the "Wegovy Linked to Sight Loss Risk" event impact Edward Margolin?

Accepted Answer

Edward Margolin, a researcher from the University of Toronto, co-authored the study and stated that Naion is likely a real side effect of semaglutide, lending credibility to the findings.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.